Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
The Pharmacokinetics of a Hemp-Based Topical Product
for
Cannabis
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 55
Code: NCT07603518
Phase 1, Recruiting
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
for
Schizophrenia
Location: Marlton NJ, Gaithersburg MD, Hollywood FL,
Sponsor: Leal Therapeutics, Inc
Sex: All
Age: 18 - 55
Code: NCT07734493
Phase 1, Recruiting
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
for
Healthy Participants
Location: Brooklyn MD, Glendale CA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 55
Code: NCT07723833
Phase 1, Recruiting
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
Location: Columbia MD, Nashville TN, Denver CO, Las Vegas NV,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07637578
Phase 2, Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
for
Acute Myeloid Leukemia, Adult
Location: Baltimore MD, Chapel Hill NC, Pittsburgh PA,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Sex: All
Age: 18+
Code: NCT06652438
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Bethesda MD, St. Petersburg FL, Baton Rouge LA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07609940
Phase 4, Recruiting
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: New York NY, Morehead City NC, Glen Burnie MD,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07701993
Phase 3, Recruiting
Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II)
for
Memory Impairment
Location: Lutherville MD
Sponsor: Neurolgy Institute for Brain Health and Fitness
Sex: All
Age: 50 - 70+
Code: NCT01766180
Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Truro, Moncton, Long Island City NY, Laurelton NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase 3, Recruiting
Screen2Prevent (S2P)
for
HIV Infections
Location: Baltimore MD, Tampa FL, Atlanta GA, Memphis TN,
Sponsor: Westat
Sex: All
Age: 14 - 24
Code: NCT07728123
Recruiting
Transventricular Off-pump Mitral Valve Repair
for
Mitral Valve (MV) Regurgitation
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21+
Code: NCT07726173
Recruiting
Music Therapy for Patients With Alzheimer's Disease
for
Mild Cognitive Impairment, Alzheimer Disease
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 70+
Code: NCT05151562
Recruiting
Impact of Manual Therapy on Laryngeal Function Following Total Thyroidectomy
for
Total Thyroidectomy
Location: Baltimore MD, Bethesda MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06383091
Recruiting
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study